Michael A. Levesque

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 407 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +11

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

Herbert Yu, M Giai, Eleftherios P. Diamandis et al. · PubMed · 1995 · 172 citations

Tumor Biology, Prognostic Biomarkers, Urology +13

Prostate‐Specific antigen expression by various tumors

Michael A. Levesque, He Hu, Eleftherios P. Diamandis et al. · Journal of Clinical Laboratory Analysis · 1995 · 134 citations

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

Michael A. Levesque, Dionyssios Katsaros, He Yu et al. · Cancer · 1995 · 128 citations